Wallace Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-505
| Closed | -$251K | – | 85 |
|
2025
Q1 | $251K | Hold |
505
| – | – | 0.03% | 63 |
|
2024
Q4 | $263K | Hold |
505
| – | – | 0.04% | 63 |
|
2024
Q3 | $312K | Sell |
505
-25
| -5% | -$15.5K | 0.04% | 65 |
|
2024
Q2 | $293K | Buy |
530
+150
| +39% | +$83K | 0.04% | 63 |
|
2024
Q1 | $221K | Sell |
380
-900
| -70% | -$523K | 0.03% | 73 |
|
2023
Q4 | $679K | Buy |
1,280
+30
| +2% | +$15.9K | 0.1% | 47 |
|
2023
Q3 | $633K | Sell |
1,250
-10
| -0.8% | -$5.06K | 0.1% | 50 |
|
2023
Q2 | $657K | Buy |
+1,260
| New | +$657K | 0.1% | 53 |
|
2022
Q3 | – | Sell |
-380
| Closed | -$204K | – | 73 |
|
2022
Q2 | $204K | Hold |
380
| – | – | 0.03% | 68 |
|
2022
Q1 | $207K | Sell |
380
-38
| -9% | -$20.7K | 0.03% | 66 |
|
2021
Q4 | $279K | Buy |
418
+38
| +10% | +$25.4K | 0.04% | 65 |
|
2021
Q3 | $217K | Sell |
380
-20
| -5% | -$11.4K | 0.03% | 68 |
|
2021
Q2 | $202K | Buy |
+400
| New | +$202K | 0.03% | 67 |
|